BSE filing, NSE: RJKMRFR. Summary written from the filing by ALFA Finder's alert engine.
Krishanveer Forge Ltd: key numbers
- Share price
- ₹136.65
- Market cap
- ₹149.5 Cr
- Revenue (annual)
- ₹89.30 Cr
- Net profit (annual)
- ₹11.38 Cr
- P/E (TTM)
- 13.2×Sector 51.5×
- Promoter holding
- 72.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishanveer Forge Ltd
All →Krishanveer Forge Board Meeting Date
Krishanveer Forge Ltd intimated BSE that its Board will meet on 31 Oct 2026 to consider unaudited financial results for Q1 and H1 FY27. No financial figures or decisions have been announced yet.
Krishanveer Forge Legal & Regulatory
Krishanveer Forge Ltd disclosed a civil suit (Special Civil Suit No. 189/2026) challenging the company's title to a land parcel acquired in 1991. Claims total ₹4.6 Crore.
- Value
- ₹4.60 Cr
Krishanveer Forge Legal & Regulatory
Krishanveer Forge is party to a special civil suit filed by Usha Dattatraya Khatpe regarding a 1991 land sale deed. The company intends to contest the matter.
Krishanveer Forge Other Announcement
Krishanveer Forge Ltd has filed its quarterly shareholding pattern disclosure under Regulation 31(1)(b) of SEBI LODR for the quarter ended September 30, 2026.
Krishanveer Forge Management Change
Krishanveer Forge Ltd announced the re-appointment of Mr. Nitin Shyam Rajore as Whole-Time Director and appointed Mr. Ravi Kapoor and Ms. Vijeta Subhash Kulkarni as Independent Directors.
Krishanveer Forge Annual General Meeting
Krishanveer Forge's 36th AGM approved a Rs. 3.00/share dividend, director re-appointments, and new independent director appointments. All business items were transacted via video conferencing on September 18, 2026.
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.